OrganiGram Holdings (TSE:OGI) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Organigram Holdings has advanced its cannabis product selection with a $1M investment into Phylos Bioscience, aiming to meet consumer demand for new aromas and high-potency rare cannabinoids. With exclusive rights to high THCV cultivars, the company is enhancing its market position by diversifying its offerings, including unique auto-flower and rare cannabinoid products.
For further insights into TSE:OGI stock, check out TipRanks’ Stock Analysis page.